KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Merck (MRK) Leases (2019 - 2025)

Merck (MRK) has disclosed Leases for 7 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 10.0% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 10.0% increase, with the full-year FY2025 number at $1.5 billion, up 10.0% from a year prior.
  • Leases was $1.5 billion for Q4 2025 at Merck, up from $1.4 billion in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.6 billion in Q4 2021 to a low of $1.3 billion in Q4 2022.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: dropped 15.13% in 2022, then increased 10.0% in 2025.
  • Merck's Leases stood at $1.6 billion in 2021, then decreased by 15.13% to $1.3 billion in 2022, then grew by 6.76% to $1.4 billion in 2023, then fell by 4.66% to $1.4 billion in 2024, then rose by 10.0% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Leases are $1.5 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.4 billion (Q4 2023).